vimarsana.com
Home
Live Updates
Telix Accelerates Artificial Intelligence (AI) Development P
Telix Accelerates Artificial Intelligence (AI) Development P
Telix Accelerates Artificial Intelligence (AI) Development Program with Acquisition of Dedicaid
MELBOURNE, Australia, April 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the expansion of its...
Related Keywords
Switzerland ,
United States ,
Japan ,
United Kingdom ,
Belgium ,
Australia ,
Melbourne ,
Victoria ,
Canada ,
Vienna ,
Wien ,
Austria ,
Australian ,
Michael Wheatcroft ,
Mark Europe ,
Thomas Beyer ,
Dedicaid Gmbh ,
Linkedin ,
Health Canada ,
Head Of The Research Domain Quantitative Imaging ,
Drug Administration ,
Telix Pharmaceuticals Limited ,
Telix Pharmaceuticals ,
Australian Securities Exchange ,
University Vienna ,
Telix Pharmaceuticals Limited Disclosure Committee ,
Australian Therapeutic Goods Administration ,
Vienna Based Dedicaid Gmbh ,
Medical University ,
Medical University Vienna ,
United States Food ,
Chief Scientist ,
Research Domain ,
Quantitative Imaging ,
Medical Physics ,
Listing Rule ,
Nucl Med ,